Pulmonary Hypertension

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease    The Cardiology Advisor PAH hypertension is an under-diagnosed complication of adult-onset Still disease.

Ten Ways To Prove That Exercising Will Not Cure Chronic Fatigue Syndrome (ME/CFS)    ProHealth ME/CFS is not deconditioning nor are its symptoms explained by inactivity. The debility in ME/CFS is much greater than is seen with deconditioning The ...

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension    Pulmonology Advisor Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows    Pulmonary Hypertension News Top-line results of a Phase 2b clinical trial of Bellerophon's INOpulse in patients with PH associated with ILD showed improvements in physical activity.

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension    The Cardiology Advisor Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Deposit four-year-old awaits heart transplant in NYC    WBNG-TV The wait for a new heart has now passed 100 days for Jackson Vandermark, who was admitted to Morgan Stanley Children's Hospital in New York City on ...

The organization helping to bring new drugs for rare diseases to market    ABC News A research team has reason to celebrate after the Food and Drug Administration granted it approval on Friday to begin a clinical trial for a new pediatric brain ...

In HFrEF, women face poorer quality of life, receive less treatment vs. men    Healio Women with HF with reduced ejection fraction live longer than men diagnosed with HFrEF but live a poorer quality of life with greater self-reported psychological ...

10 medical tech innovations to ring in the New Year    MD Linx Ten medical technology innovations and nominees for the 2018 Prix Galien Award.

Blood test for scleroderma, systemic sclerosis biomarkers launched    Healio Specialty biotechnology company Gemelli Biotech has announced the launch of a blood test that measures anti-vinculin levels to help physicians identify the risk ...

Chinese PH Patients Form Beijing-based Advocacy Group    Pulmonary Hypertension News Pulmonary hypertension (PH) patients in China, the world's most populous nation, finally have their own advocacy organization. The iSEEK Pulmonary ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival    Medscape Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with ...

St. Antonius Hospital in Nieuwegein/Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System    Cath Lab Digest Toronto, ON, January 8, 2019 – Ventripoint Diagnostics Ltd. is pleased to announce that Dr. M.C. Post, MD, PhD Cardiologist and Dr. Marloes Huitema, MD, PhD ...

Uproar as Zambian energy drink causes 'prolonged erection lasting 6 hours'    Face2Face Africa Energy drinks usually contain added caffeine and other ingredients that are supposed to boost mental health and physical performance, but an energy drink, ...

Uptravi for PAH to receive NHS England funding 9 January 2019    Zenopa Treatment for the rare and incurable disease pulmonary arterial hypertension, which affects approximately 3,000 people in the UK, has been available in all of ...

8 Trends Affecting Your Work and Health Outcomes in 2019    Pharmaceutical Executive 2018 proved to be a pivotal year, and as we look towards 2019, key foundational policies and recommendations still need to be fleshed out. Here is our look into ...

Bellerophon Therapeutics (BLPH) Sees Unusually-High Trading Volume    Fairfield Current Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares saw strong trading volume on Monday . 1671001 shares changed hands during mid-day trading, ...

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis    BioSpace Published: Jan 09, 2019. LOS ANGELES, Jan. 9, 2019 /PRNewswire/ -- The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be ...